Investing.com - Axonics Modulation Technologies (NASDAQ: AXNX) reported third quarter EPS of $0.08, $0.13 better than the analyst estimate of $-0.05. Revenue for the quarter came in at $93.1M versus the consensus estimate of $89.6M.
Guidance
Axonics Modulation Technologies sees FY 2023 revenue of $362.00M versus the analyst consensus of $358.70M.
Axonics Modulation Technologies's stock price closed at $49.50. It is down -17.57% in the last 3 months and down -32.24% in the last 12 months.
Axonics Modulation Technologies saw 1 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Axonics Modulation Technologies's stock price’s past reactions to earnings here.
According to InvestingPro, Axonics Modulation Technologies's Financial Health score is "great performance".
Check out Axonics Modulation Technologies's recent earnings performance, and Axonics Modulation Technologies's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar